Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6307
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhibiting IL-17A and IL-17F in Rheumatic Disease: Therapeutics Help to Elucidate Disease Mechanisms ; volume:24 ; number:10 ; day:21 ; month:7 ; year:2022 ; pages:310-320 ; date:10.2022
Current rheumatology reports ; 24, Heft 10 (21.7.2022), 310-320, 10.2022
- Urheber
-
Tam, Hoi Ki Joshua
Robinson, Philip C.
Nash, Peter
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11926-022-01084-4
- URN
-
urn:nbn:de:101:1-2022113021103113804802
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tam, Hoi Ki Joshua
- Robinson, Philip C.
- Nash, Peter
- SpringerLink (Online service)
Ähnliche Objekte (12)
Rheumatic disease
Rheumatic Heart Disease in Children
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Rheumatic heart disease: infectious disease origin, chronic care approach
Human antibody therapeutics for viral disease
Recent developments in Alzheimer's disease therapeutics
Review: Microbial Therapeutics for Liver Disease
Next generation therapeutics for Alzheimer's disease
Splicing therapeutics for A lzheimer's disease
Vasculitis, rheumatic disease, and the nervous system
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
Rheumatic disease
Rheumatic Heart Disease in Children
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Rheumatic heart disease: infectious disease origin, chronic care approach
Human antibody therapeutics for viral disease
Recent developments in Alzheimer's disease therapeutics
Review: Microbial Therapeutics for Liver Disease
Next generation therapeutics for Alzheimer's disease
Splicing therapeutics for A lzheimer's disease
Vasculitis, rheumatic disease, and the nervous system
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?
Diagnostic value of salivary CRP and IL-6 in patients undergoing anti-TNF-alpha therapy for rheumatic disease
Rheumatic disease
Rheumatic Heart Disease in Children
Anti-IL-17 Inhibits PINK1/Parkin Autophagy and M1 Macrophage Polarization in Rheumatic Heart Disease
Rheumatic heart disease: infectious disease origin, chronic care approach
Human antibody therapeutics for viral disease
Recent developments in Alzheimer's disease therapeutics
Review: Microbial Therapeutics for Liver Disease
Next generation therapeutics for Alzheimer's disease
Splicing therapeutics for A lzheimer's disease
Vasculitis, rheumatic disease, and the nervous system
Prophylaxis of Rheumatic Fever/Rheumatic Heart Disease–Penicillin or Azithromycin, Who Wins?